Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy. [electronic resource]
Producer: 20200417ISSN:- 1946-6242
- Adenocarcinoma of Lung -- drug therapy
- Animals
- Basic-Leucine Zipper Transcription Factors -- metabolism
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Line, Tumor
- Cell-Penetrating Peptides -- pharmacokinetics
- DNA -- metabolism
- Disease Models, Animal
- E-Box Elements -- genetics
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Mice, Inbred C57BL
- Peptide Fragments -- administration & dosage
- Promoter Regions, Genetic -- genetics
- Protein Binding -- drug effects
- Protein Multimerization -- drug effects
- Proto-Oncogene Proteins c-myc -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.